The Balanced Opioid Initiative: protocol for a clustered, sequential, multiple-assignment randomized trial to construct an adaptive implementation strategy to improve guideline-concordant opioid prescribing in primary care

Andrew Quanbeck, Daniel Almirall, Nora Jacobson, Randall T Brown, Jillian K Landeck, Lynn Madden, Andrew Cohen, Brienna M F Deyo, James Robinson, Roberta A Johnson, Nicholas Schumacher, Andrew Quanbeck, Daniel Almirall, Nora Jacobson, Randall T Brown, Jillian K Landeck, Lynn Madden, Andrew Cohen, Brienna M F Deyo, James Robinson, Roberta A Johnson, Nicholas Schumacher

Abstract

Background: Rates of opioid prescribing tripled in the USA between 1999 and 2015 and were associated with significant increases in opioid misuse and overdose death. Roughly half of all opioids are prescribed in primary care. Although clinical guidelines describe recommended opioid prescribing practices, implementing these guidelines in a way that balances safety and effectiveness vs. risk remains a challenge. The literature offers little help about which implementation strategies work best in different clinical settings or how strategies could be tailored to optimize their effectiveness in different contexts. Systems consultation consists of (1) educational/engagement meetings with audit and feedback reports, (2) practice facilitation, and (3) prescriber peer consulting. The study is designed to discover the most cost-effective sequence and combination of strategies for improving opioid prescribing practices in diverse primary care clinics.

Methods/design: The study is a hybrid type 3 clustered, sequential, multiple-assignment randomized trial (SMART) that randomizes clinics from two health systems at two points, months 3 and 9, of a 21-month intervention. Clinics are provided one of four sequences of implementation strategies: a condition consisting of educational/engagement meetings and audit and feedback alone (EM/AF), EM/AF plus practice facilitation (PF), EM/AF + prescriber peer consulting (PPC), and EM/AF + PF + PPC. The study's primary outcome is morphine-milligram equivalent (MME) dose by prescribing clinicians within clinics. The study's primary aim is the comparison of EM/AF + PF + PPC versus EM/AF alone on change in MME from month 3 to month 21. The secondary aim is to derive cost estimates for each of the four sequences and compare them. The exploratory aim is to examine four tailoring variables that can be used to construct an adaptive implementation strategy to meet the needs of different primary care clinics.

Discussion: Systems consultation is a practical blend of implementation strategies used in this case to improve opioid prescribing practices in primary care. The blend offers a range of strategies in sequences from minimally to substantially intensive. The results of this study promise to help us understand how to cost effectively improve the implementation of evidence-based practices.

Trial registration: NCT04044521 (ClinicalTrials.gov). Registered 05 August 2019.

Keywords: Adaptive implementation strategy; Audit and feedback; Clinical guideline adoption; Clustered SMART; Educational meetings; Multi-phase optimization strategy; Opioid prescribing; Practice facilitation; Prescriber peer consulting; Primary care.

Conflict of interest statement

The other authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Theoretical and empirical framework. Sources: Ferlie and Shortell [22]; Powell [19]
Fig. 2
Fig. 2
Study design. EM: Educational/engagement meeting; AF: Audit with monthly feedback reports; R: Randomization point; PF: Practice facilitation; PPC: prescriber peer consulting
Fig. 3
Fig. 3
Participant flow. EM, Educational/engagement meeting; AF, Audit with monthly feedback reports; PF, Practice facilitation; PPC, prescriber peer consulting

References

    1. Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain — United States, 2016. MMWR Recomm Rep 2016;65(No. RR-1):1–49. doi: 10.15585/mmwr.rr6501e1external icon..
    1. Centers for Disease Control and Prevention (CDC). Vital signs: opioid prescribing. U.S. Department of Health and Human Services. Sept 26, 2017. . Accessed 17 Oct 2019..
    1. Daubresse M, Chang HY, Yu Y, Viswanathan S, Shah ND, Stafford RS, et al. Ambulatory diagnosis and treatment of nonmalignant pain in the United States, 2000-2010. Med Care. 2013;51:870–878. doi: 10.1097/MLR.0b013e3182a95d8.
    1. Edlund MJ, Martin BC, Fan MY, Devries A, Braden JB, Sullivan MD. Risks for opioid abuse and dependence among recipients of chronic opioid therapy: results from the TROUP study. Drug Alcohol Depend. 2010;112:90–98. doi: 10.1016/j.drugalcdep.2010.05.017.
    1. Bohnert AS, Valenstein M, Bair MJ, Ganoczy D, McCarthy JF, Ilgen MA, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 2011;305:1315–1321. doi: 10.1001/jama.2011.370.
    1. Dunn KM, Saunders KW, Rutter CM, Banta-Green CJ, Merrill JO, Sullivan MD, et al. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med. 2010;152:85–92. doi: 10.7326/0003-4819-152-2-201001190-00006.
    1. Edlund MJ, Martin BC, Devries A, Fan MY, Braden JB, Sullivan MD. Trends in use of opioids for chronic noncancer pain among individuals with mental health and substance use disorders: the TROUP study. Clin J Pain. 2010;26(1):1–8. doi: 10.1097/AJP.0b013e3181b99f35.
    1. Weisner CM, Campbell CI, Ray GT, Saunders K, Merrill JO, Banta-Green C, et al. Trends in prescribed opioid therapy for non-cancer pain for individuals with prior substance use disorders. Pain. 2009;145:287–293. doi: 10.1016/j.pain.2009.05.006.
    1. Banta-Green CJ, Merrill JO, Doyle SR, Boudreau DM, Calsyn DA. Opioid use behaviors, mental health and pain--development of a typology of chronic pain patients. Drug Alcohol Depend. 2009;104:34–42. doi: 10.1016/j.drugalcdep.2009.03.021.
    1. Vankata HG, Gaurav C, Ram S, Talari G. Co-prescription of opioids and benzodiazepines. BMJ. 2017;356:j760.
    1. Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10:113–130. doi: 10.1016/j.jpain.2008.10.008.
    1. National Center for Health Statistics, Centers for Disease Control and Prevention (CDC). Provisional Drug Overdose Death Counts. 2019. Accessed 19 Oct 2019..
    1. Dowell D, Haegerich T, Chou R. No shortcuts to safer opioid prescribing. N Engl J Med. 2019;380:2285–2287. doi: 10.1056/NEJMp1904190.
    1. US Department of Health and Human Services. HHS guide for clinicians on the appropriate dosage reduction or discontinuation of long-term opioid analgesics. 2019. . Accessed 19 Oct 2019..
    1. Dowell D, Compton WM, Giroir BP. Patient-centered reduction or discontinuation of long-term opioid analgesics: the HHS guide for clinicians. JAMA. 2019. 10.1001/jama.2019.16409..
    1. Levine DM, Linder JA, Landon BE. The quality of outpatient care delivered to adults in the United States, 2002 to 2013. JAMA Intern Med. 2016;176:1778–1790. doi: 10.1001/jamainternmed.2016.6217.
    1. Lau R, Stevenson F, Ong BN, Dziedzic K, Treweek S, Eldridge S, et al. Achieving change in primary care—effectiveness of strategies for improving implementation of complex interventions: systematic review of reviews. BMJ Open. 2015;5:e009993. doi: 10.1136/bmjopen-2015-009993.
    1. Quanbeck A, Brown RT, Zgierska AE, Jacobson N, Robinson JM, Johnson RA, et al. A randomized matched-pairs study of feasibility, acceptability, and effectiveness of systems consultation: a novel implementation strategy for adopting clinical guidelines for opioid prescribing in primary care. Implement Sci. 2018;13:21. doi: 10.1186/s13012-018-0713-1.
    1. Powell BJ, Waltz TJ, Chinman MJ, Damschroder LJ, Smith JL, Matthieu MM, et al. A refined compilation of implementation strategies: results from the Expert Recommendations for Implementing Change (ERIC) project. Implement Sci. 2015;10:21. doi: 10.1186/s13012-015-0209-1.
    1. Proctor EK, Powell BJ, McMillen JC. Implementation strategies: recommendations for specifying and reporting. Implement Sci. 2013;8:139. doi: 10.1186/1748-5908-8-139.
    1. Jacobson N, Johnson R, Deyo B, Alagoz E, Quanbeck A. Systems consultation for opioid prescribing in primary care: a qualitative study of adaptation. BMJ Qual Saf. 2019;28:397–404. doi: 10.1136/bmjqs-2018-008160.
    1. Ferlie EB, Shortell SM. Improving the quality of health care in the United Kingdom and the United States: a framework for change. Milbank Q. 2001;79:281–315. doi: 10.1111/1468-0009.00206.
    1. Wensing M, Bosch M, Grol R. Developing and selecting interventions for translating knowledge to action. CMAJ. 2010;182:E85–E88. doi: 10.1503/cmaj.081233.
    1. Baker R, Camosso-Stefinovic J, Gillies C, Shaw EJ, Cheater F, Flottorp S, et al. Tailored interventions to address determinants of practice. Cochrane Database Syst Rev 2015, Issue 4. Art. No.: CD005470. DOI: 10.1002/14651858.CD005470.pub3..
    1. Almirall, D., Nahum-Shani, I., Wang, L., & Kasari, C. (2018). Experimental designs for research on adaptive interventions: Singly and sequentially randomized trials. In Optimization of Behavioral, Biobehavioral, and Biomedical Interventions (pp. 89-120). Springer, Cham..
    1. Almirall D, Chronis-Tuscano A. Adaptive interventions in child and adolescent mental health. J Clin Child Adolesc Psychol 2016;45(4):383-395. PubMed PMID: ; PubMed Central PMCID: ..
    1. Kilbourne, AM, Smith, SS, Choi, SY, Koschmann, E, Liebrecht, C, Rusch, A, Abelson, JL, Eisenberg, D, Himle, JA, Fitzgerald, K, and Almirall, D (2018). Adaptive school-based implementation of CBT (ASIC): clustered-SMART for building an optimized adaptive implementation intervention to improve uptake of mental health interventions in schools. Implementation Science, 13 (1) 119. DOI: 10.1186/s13012-018-0808-8. PMCID: PMC6126013..
    1. Kilbourne AM, Almirall D, Goodrich DE, Lai Z, Abraham KM, Nord KM, Bowersox NW. Enhancing outreach for persons with serious mental illness: 12-month results from a cluster randomized trial of an adaptive implementation strategy. Implement Sci 2014;9:163. PubMed PMID: ; PubMed Central PMCID: ..
    1. Kilbourne AM, Almirall D, Eisenberg D, Waxmonsky J, Goodrich DE, Fortney JC, Kirchner JE, Solberg LI, Main D, Bauer MS, Kyle J, Murphy SA, Nord KM, Thomas MR. Protocol: Adaptive Implementation of Effective Programs Trial (ADEPT): cluster randomized SMART trial comparing a standard versus enhanced implementation intervention to improve outcomes of a mood disorders program. Implement Sci 2014;9:132. PubMed PMID: ; PubMed Central PMCID: ..
    1. Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012;50:217–226. doi: 10.1097/MLR.0b013e3182408812.
    1. Alagoz E, Chih MY, Hitchcock M, Brown R, Quanbeck A. The use of external change agents to promote quality improvement and organizational change in healthcare organizations: a systematic review. BMC Health Serv Res. 2018;18:42. doi: 10.1186/s12913-018-2856-9.
    1. Gustafson DH, Johnson KA, Capoccia V, Cotter F, Ford JH, II, et al. The NIATx model: process improvement in behavioral health. Madison WI: University of Wisconsin – Madison; 2011.
    1. Delbecq AL, Van de Ven AH, Gustafson DH. Group techniques for program planning: a guide to nominal group and Delphi processes. Glenview, IL: Scott Foresman & Company; 1975..
    1. Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health. 1999;89:1322–1327. doi: 10.2105/ajph.89.9.1322.
    1. Nahum-Shani I, Qian M, Almirall D, Pelham WE, Gnagy B, Fabiano GA. et a. Q-learning: a data analysis method for constructing adaptive interventions. Psychol Methods. 2012;17:478–494. doi: 10.1037/a0029373.
    1. Gold MR, Siegel JE, Russell L, Weinstein MC, editors. Cost-effectiveness in health and medicine: report of the panel on cost-effectiveness in health and medicine. New York: Oxford University Press; 1996.
    1. Sanders GD, Neumann PJ, Basu A, Brock DW, Feeny D, Krahn M, et al. Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine. JAMA. 2016;316:1093–1103. doi: 10.1001/jama.2016.12195.
    1. Saldana L, Chamberlain P, Bradford WD, Campbell M, Landsverk J. The cost of implementing new strategies (COINS): a method for mapping implementation resources using the stages of implementation completion. Child Youth Sev Rev. 2014;39:177–182. doi: 10.1016/j.childyouth.2013.10.006.
    1. Fenwick E, Marshall DA, Levy AR, Nichol G. Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation. BMC Health Serv Res. 2006;6:52. doi: 10.1186/1472-6963-6-52.
    1. Loudon K, Treweek S, Sullivan F, Donnan P, Thorpe KE, Zwarenstein M. The PRECIS-2 tool: designing trials that are fit for purpose. BMJ. 2015;350:h2147. doi: 10.1136/bmj.h2147.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다